General Dynamics Corporation vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? General Dynamics Corporation trades at $330.88 (market cap $89.26B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.46 (market cap $2.27B). The key difference: General Dynamics Corporation is far larger — about 39.3× SELLAS Life Sciences Group Inc. Common Stock's market cap, and General Dynamics Corporation pays a 1.93% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| GD | SLS | |
|---|---|---|
Market Cap | $89.26B | $2.27B |
Volume | 1,496,273 | 4,179,659 |
Sector | Industrials | Health |
52-Week High | $395.97 | $15.46 |
52-Week Low | $312.53 | $1.39 |
Typical Hold Time | 85 Days | — |
Enterprise Value | $94.40B | $2.14B |
Dividend Yield | 1.93% | — |
Signals from Pluang's Aura AI — not financial advice
General Dynamics (GD) trades at $326.63, down 1.42% amid bearish technical signals, though fundamentals remain solid with consistent earnings beats and strong defense contract visibility. The stock shows oversold RSI readings while maintaining healthy profitability metrics including 8.18% net margin and 17.8% ROE. Recent Pentagon spending focus and dividend stability support the investment case despite near-term price pressure.
GD presents a compelling value opportunity with 57% analyst buy ratings and $420.57 consensus target representing 29% upside. Defense budget tailwinds and submarine/vehicle demand provide growth catalysts, though technical weakness and defense sector volatility pose near-term risks. The company's consistent cash flow generation and dividend payments offer stability for long-term investors.
No Aura AI signal available yet.
Trailing returns across standard periods
General Dynamics is a defense contractor and business jet manufacturer. The firm's segments include aerospace, combat systems, marine, and technologies. The company's aerospace segment creates Gulfstream business jets. Combat system produces land-based combat vehicles, such as the M1 Abrams tank. The marine subsegment creates nuclear-powered submarines, among other things. The technologies segment contains two main units, an IT business that primarily serves the government market and a mission systems business that focuses on products that provide command, control, computers, intelligence, surveillance, and reconnaissance capabilities to the military.
Read more on GD →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →